Difficulty: Medium
Average Score: 90%
Practice
What describes a primary use of biologic therapy in cancer treatment?
Correct answer
C
Rationale
In cancer treatment, the primary use of biologic therapy is to enhance or supplement the effects of the host's immune responses to tumor cells that produce flu-like symptoms (Option C). This is because biologic therapies, such as monoclonal antibodies or immune checkpoint inhibitors, work by targeting specific components of the immune system to help recognize and attack cancer cells more effectively. By boosting the immune response against cancer, these therapies can lead to better outcomes for patients.
Option A is incorrect because protecting normal, rapidly reproducing cells of the gastrointestinal system from damage during chemotherapy is typically the role of supportive care medications or growth factors, not biologic therapies used in cancer treatment.
Option B is also incorrect as preventing fatigue associated with chemotherapy and high-dose radiation as seen with bone marrow depression is primarily managed through supportive care measures such as blood transfusions or growth factors, not biologic therapies.
Option D is incorrect because depressing the immune system and circulating lymphocytes or replacing central nervous system deficits are not the primary goals of biologic therapy in cancer treatment. Biologic therapies aim to stimulate or modulate the immune system to target cancer cells more effectively rather than suppress it.
Educationally, understanding the rationale behind using biologic therapy in cancer treatment is crucial for healthcare professionals to make informed decisions about treatment options for their patients. Knowing the specific mechanisms of action and goals of biologic therapies can help ensure the best possible outcomes for individuals undergoing cancer treatment.
Option A is incorrect because protecting normal, rapidly reproducing cells of the gastrointestinal system from damage during chemotherapy is typically the role of supportive care medications or growth factors, not biologic therapies used in cancer treatment.
Option B is also incorrect as preventing fatigue associated with chemotherapy and high-dose radiation as seen with bone marrow depression is primarily managed through supportive care measures such as blood transfusions or growth factors, not biologic therapies.
Option D is incorrect because depressing the immune system and circulating lymphocytes or replacing central nervous system deficits are not the primary goals of biologic therapy in cancer treatment. Biologic therapies aim to stimulate or modulate the immune system to target cancer cells more effectively rather than suppress it.
Educationally, understanding the rationale behind using biologic therapy in cancer treatment is crucial for healthcare professionals to make informed decisions about treatment options for their patients. Knowing the specific mechanisms of action and goals of biologic therapies can help ensure the best possible outcomes for individuals undergoing cancer treatment.